Laboratory of Immunomodulation and Regenerative Cell Therapy, Department of Internal Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Cells. 2024 May 30;13(11):941. doi: 10.3390/cells13110941.
Regulatory T cells (Tregs) are essential to maintain immune homeostasis by promoting self-tolerance. Reduced Treg numbers or functionality can lead to a loss of tolerance, increasing the risk of developing autoimmune diseases. An overwhelming variety of human Tregs has been described, based on either specific phenotype, tissue compartment, or pathological condition, yet the bulk of the literature only addresses CD25-positive and CD127-negative cells, coined by naturally occurring Tregs (nTregs), most of which express the transcription factor Forkhead box protein 3 (FOXP3). While the discovery of FOXP3 was seminal to understanding the origin and biology of nTregs, there is evidence in humans that not all T cells expressing FOXP3 are regulatory, and that not all Tregs express FOXP3. Namely, the activation of human T cells induces the transient expression of FOXP3, irrespective of whether they are regulatory or inflammatory effectors, while some induced T cells that may be broadly defined as Tregs (e.g., Tr1 cells) typically lack demethylation and do not express FOXP3. Furthermore, it is unknown whether and how many nTregs exist without FOXP3 expression. Several other candidate regulatory molecules, such as GITR, Lag-3, GARP, GPA33, Helios, and Neuropilin, have been identified but subsequently discarded as Treg-specific markers. Multiparametric analyses have uncovered a plethora of Treg phenotypes, and neither single markers nor combinations thereof can define all and only Tregs. To date, only the functional capacity to inhibit immune responses defines a Treg and distinguishes Tregs from inflammatory T cells (Teffs) in humans. This review revisits current knowledge of the Treg universe with respect to their heterogeneity in phenotype and function. We propose that it is unavoidable to characterize human Tregs by their phenotype in combination with their function, since phenotype alone does not unambiguously define Tregs. There is an unmet need to align the expression of specific markers or combinations thereof with a particular suppressive function to coin functional Treg entities and categorize Treg diversity.
调节性 T 细胞(Tregs)对于通过促进自身耐受来维持免疫稳态至关重要。Treg 数量或功能的减少可导致耐受丧失,增加自身免疫性疾病的风险。已经根据特定表型、组织隔室或病理状况描述了大量的人类 Tregs,但大多数文献仅涉及 CD25 阳性和 CD127 阴性细胞,这些细胞由天然存在的 Tregs(nTregs)组成,其中大多数表达转录因子叉头框蛋白 3(FOXP3)。虽然 FOXP3 的发现对于理解 nTregs 的起源和生物学具有重要意义,但在人类中,有证据表明并非所有表达 FOXP3 的 T 细胞都是调节性的,并且并非所有 Tregs 都表达 FOXP3。即,人类 T 细胞的激活会诱导 FOXP3 的瞬时表达,无论它们是调节性还是炎症效应物,而一些被广泛定义为 Tregs(例如 Tr1 细胞)的诱导性 T 细胞通常缺乏去甲基化且不表达 FOXP3。此外,尚不清楚是否存在不表达 FOXP3 的 nTregs 以及其数量。已经鉴定出其他几种候选调节性分子,例如 GITR、Lag-3、GARP、GPA33、Helios 和 Neuropilin,但随后将其作为 Treg 特异性标志物丢弃。多参数分析揭示了大量 Treg 表型,并且单一标志物或其组合都不能定义所有和仅有的 Tregs。迄今为止,只有抑制免疫反应的功能能力定义了 Treg,并将 Treg 与人类中的炎症性 T 细胞(Teffs)区分开来。这篇综述重新审视了 Treg 领域关于其表型和功能异质性的现有知识。我们提出,由于表型本身不能明确定义 Treg,因此必须通过其表型与功能相结合来描述人类 Treg。因此,迫切需要将特定标志物的表达或其组合与特定抑制功能相关联,以鉴定具有特定抑制功能的功能性 Treg 实体并对 Treg 多样性进行分类。